221
Views
14
CrossRef citations to date
0
Altmetric
Review

Molecular genetics of high-risk chronic lymphocytic leukemia

&
Pages 593-602 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Shannon R. McCurdy & Mark J. Levis. (2018) Emerging molecular predictive and prognostic factors in acute myeloid leukemia. Leukemia & Lymphoma 59:9, pages 2021-2039.
Read now
Stefano Molica, Maura Brugiatelli, Fortunato Morabito, Felicetto Ferrara, Emilio Iannitto, Nicola Di Renzo, Silvana Capalbo, Pellegrino Musto & Francesco Di Raimondo. (2013) Treatment of elderly patients with chronic lymphocytic leukemia: an unmet cinical need. Expert Review of Hematology 6:4, pages 441-449.
Read now

Articles from other publishers (12)

Heba Alkhatabi, Elrashed B. Yasin, Zeenat Mirza, Raed Alserihi, Raed Felimban, Aisha Elaimi, Manal Shaabad, Lina Alharbi, Hameeda Ahmed, Abdulrahman M. Alameer, Abdullah Ebraheem Mathkoor & Ahmed Salleh Barefah. (2022) TP53 Expression and Mutational Analysis in Hematological Malignancy in Jeddah, Saudi Arabia. Diagnostics 12:3, pages 724.
Crossref
Kyle Crassini, William S. Stevenson, Stephen P. Mulligan & O. Giles Best. (2019) Molecular pathogenesis of chronic lymphocytic leukaemia. British Journal of Haematology 186:5, pages 668-684.
Crossref
Hongyang Lu, Shifeng Yang, Huineng Zhu, Xiaoling Tong, Fajun Xie, Jing Qin, Na Han, Xue Wu, Yun Fan, Yang W. Shao & Weimin Mao. (2018) Targeted next generation sequencing identified clinically actionable mutations in patients with esophageal sarcomatoid carcinoma. BMC Cancer 18:1.
Crossref
Chunfa Huang, Yifan Tu & Carl E. Freter. (2018) Fludarabine-resistance associates with ceramide metabolism and leukemia stem cell development in chronic lymphocytic leukemia. Oncotarget 9:69, pages 33124-33137.
Crossref
Paola Orsini, Crescenzio F. Minervini, Cosimo Cumbo, Luisa Anelli, Antonella Zagaria, Angela Minervini, Nicoletta Coccaro, Giuseppina Tota, Paola Casieri, Luciana Impera, Elisa Parciante, Claudia Brunetti, Annamaria Giordano, Giorgina Specchia & Francesco Albano. (2018) Design and MinION testing of a nanopore targeted gene sequencing panel for chronic lymphocytic leukemia. Scientific Reports 8:1.
Crossref
Elaine Vickers. 2018. A Beginner's Guide to Targeted Cancer Treatments. A Beginner's Guide to Targeted Cancer Treatments 259 312 .
A Stengel, W Kern, T Haferlach, M Meggendorfer, A Fasan & C Haferlach. (2016) The impact of TP53 mutations and TP53 deletions on survival varies between AML, ALL, MDS and CLL: an analysis of 3307 cases. Leukemia 31:3, pages 705-711.
Crossref
Lee Admoni-Elisha, Itay Nakdimon, Anna Shteinfer, Tal Prezma, Tasleem Arif, Nir Arbel, Anna Melkov, Ori Zelichov, Itai Levi & Varda Shoshan-Barmatz. (2016) Novel Biomarker Proteins in Chronic Lymphocytic Leukemia: Impact on Diagnosis, Prognosis and Treatment. PLOS ONE 11:4, pages e0148500.
Crossref
P. Baliakas, M. Mattsson, K. Stamatopoulos & R. Rosenquist. (2016) Prognostic indices in chronic lymphocytic leukaemia: where do we stand how do we proceed?. Journal of Internal Medicine 279:4, pages 347-357.
Crossref
Stefano Molica, Diana Giannarelli, Rosanna Mirabelli, Luciano Levato, Antonio Russo, Maria Linardi, Massimo Gentile & Fortunato Morabito. (2016) Unavailability of thymidine kinase does not preclude the use of German comprehensive prognostic index: results of an external validation analysis in early chronic lymphocytic leukemia and comparison with MD Anderson Cancer Center model. European Journal of Haematology 96:1, pages 72-77.
Crossref
Prerna Mewawalla & Sunita Nathan. (2014) Role of allogeneic transplantation in patients with chronic lymphocytic leukemia in the era of novel therapies: a review. Therapeutic Advances in Hematology 5:5, pages 139-152.
Crossref
Stefano Molica, Diana Giannarelli, Massimo Gentile, Giovanna Cutrona, Nicola Di Renzo, Francesco Di Raimondo, Antonino Neri, Massimo Federico, Manlio Ferrarini & Fortunato Morabito. (2013) The utility of two prognostic models for predicting time to first treatment in early chronic lymphocytic leukemia patients: Results of a comparative analysis. Leukemia Research 37:8, pages 943-947.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.